- This event has passed.
2018 Access to Innovation
January 17, 2018 - January 18, 2018
On Wednesday, January 17 and Thursday, January 18, 2018, LifeSciences BC held the 2018 Access to Innovation event.
2018 ACCESS TO INNOVATION
Thank you to our event supporters!
BDC Capital joined as co-presenter this year, following on the success of the first-ever Canadian Corporate Innovation Summit.
Speaker Bios:
2018 Access to Innovation Speakers – Day 1
2018 Access to Innovation Speakers – Day 2
Deloitte Conference Materials:
Deloitte-uk-life-sciences-health-care-predictions-2022 Western Canada Edition
Confirmed Speakers:
Ohad Arazi: Vice President & General Manager, TELUS Health Living Labs
Dr. Cedric Bisson: Partner, Teralys Capital
Ela Borenstein, Program Director, BDC Capital
Vern Brownell: CEO, D-Wave Systems
Dr. Pieter Cullis, Director, NanoMedicines Research Group; Professor, Department of Biochemistry and Molecular Biology
Dr. Elai Davicioni: President & Chief Scientific Officer, GenomeDX Biosciences
Karimah Es Sabar: CEO & Partner, Quark Venture Inc and the Director of the Global Health Sciences Fund
Pamela Fralick: President, Innovative Medicines Canada
Dr. Mark Gelfer: Chairman, GenXys Health Care Systems Inc.
Dr. Tom Hawes: Managing Director, BlueCross BlueShield Venture Fund
Peter Jones: Industry Lead – Healthcare, Microsoft Canada
Dr. Steven Jones, Associate Director and Head, Bioinformatics, Genome Sciences Centre, Vancouver
Dr. Dermot Kelleher, Dean, Faculty of Medicine, University of British Columbia
Erik Kiss: CEO, Imaging Reality
Dion Madsen, Senior Managing Partner, Healthcare Fund, BDC Venture Capital
Dr. Steve Mathias: Clinical Assistant Professor, UBC
David McGovern: Associate Deputy Minister, Innovation, Science and Economic Development Canada
Dr. Joby McKenzie: Senior Vice President Business Development, LifeLabs
Dr. Peter McWilliams: Managing Director, Sanderling Ventures
Fazil Mihlar: Deputy Minister, Ministry of Jobs, Trade & Technology, Government of British Columbia
Dr. Gail Murphy, Vice-President Research & Innovation, UBC
Sue Paish: Healthcare Leader
Dr. Jeff Pike: Clinical Transformation Lead, Providence Health Care
Dr. Simon Pimstone: President & CEO, Xenon Pharmaceuticals, Founder, SAVE BC
Dr. Mohammed Qadir: President & Chief Scientific Officer, Fusion Genomics Corporation
Dr. Alan Rabinowitz: Co-Founder, Chief Medical Officer & a Director PHEMI Health Systems
Dr. Rachael Ritchie: Vice President, Strategy and Partnerships, The Centre for Drug Research & Development
Robert Scully: Director, Manulife Capital Ventures
Mike Standing, Leader Life Sciences and Health Care EMEA Region, Deloitte
Dr. Lesley Stolz: Head, JLABS California
Bill Tam: Interim Co-Chair, Canada’s Digital Technology Supercluster
Karen Wichuk: Executive Lead, Health City Edmonton
Dr. Peter Zandstra, Director, School of Biomedical Engineering, UBC, Director, Michael Smith Laboratories, UBC
Dr. Steven Xanthoudakis: Chief Business Development Officer, CQDM Quebec Consortium for Drug Discovery
Conference Partner:
Luncheon Sponsors: GSK
Presenting Afternoon Sponsor:
Session Sponsors:
Reception Sponsor:
Breakfast & Morning Refreshment Sponsor:
General Supporter: GenomeBC